BackComprehensive Study Notes: Principles of Disease, Pathogenicity, Immunity, Vaccines, and Antimicrobial Drugs
Study Guide - Smart Notes
Tailored notes based on your materials, expanded with key definitions, examples, and context.
Principles of Disease
Modes of Disease Transmission
Understanding how diseases are transmitted is essential for controlling and preventing infections. Transmission can occur through various routes, each with distinct mechanisms.
Contact Transmission: Direct physical contact between individuals (e.g., touching, kissing).
Droplet Transmission: Spread via respiratory droplets expelled during coughing, sneezing, or talking. Droplets typically travel short distances (less than 1 meter).
Vehicle Transmission: Involves transmission through a non-living medium such as air, water, or food. This does not involve direct organism-to-organism transfer.
Airborne Transmission: Pathogens are carried on dust or droplet nuclei suspended in air, traveling longer distances than droplets.
Animal Vectors: Arthropods (e.g., ticks, fleas, mosquitoes, flies) can transmit pathogens.
Mechanical Transmission: The vector carries the pathogen on its body surface.
Biological Transmission: The pathogen reproduces within the vector and is transmitted via bites or feces.
Table 14.3: (Comparison of mechanical vs. biological transmission.)
Transmission Type | Mechanism | Example Vector |
|---|---|---|
Mechanical | Pathogen carried externally | Housefly |
Biological | Pathogen develops inside vector | Mosquito (malaria) |
Healthcare Acquired Infections (HAIs)
HAIs, also known as nosocomial infections, originate in healthcare settings and are a significant cause of morbidity and mortality.
Origin: Can arise from the hospital environment, staff, or other patients.
Harm: HAIs can complicate treatment, prolong hospital stays, and increase healthcare costs.
Common Examples: Urinary tract infections (catheters), surgical site infections, pneumonia (ventilators).
Table 14.4: (Examples and sites of HAIs.)
Infection Type | Common Site | Associated Procedure |
|---|---|---|
UTI | Urinary tract | Catheterization |
Pneumonia | Lungs | Ventilator use |
Surgical Site Infection | Incision site | Surgery |
Table 14.5: (Transmission routes in healthcare settings.)
Route | Example |
|---|---|
Staff to Patient | Improper hand hygiene |
Patient to Staff | Needlestick injury |
Patient to Patient | Shared equipment |
Epidemiology
Epidemiology is the study and analysis of disease patterns in defined populations.
Case Reporting: Systematic documentation of disease cases to monitor and control outbreaks.
Nationally Notifiable Diseases: Certain infectious diseases must be reported to health authorities (see Table 14.6 for examples).
Microbial Mechanisms of Pathogenicity
Pathogenicity and Virulence
Pathogenicity is the ability of a microorganism to cause disease, while virulence refers to the degree of pathogenicity.
Requirements for Pathogenicity: Entry into the host, growth, causing damage, and evading host defenses.
Virulence Factors: Traits that enhance a pathogen's ability to cause disease (e.g., toxins, capsules).
Entry Portals for Pathogens
Pathogens enter the host through specific portals, which can be breached by trauma or medical procedures.
Common Portals: Mucous membranes, skin, parenteral route (injection, bites).
Table 15.1: (Entry portals and examples.)
Portal | Example Pathogen |
|---|---|
Respiratory tract | Influenza virus |
Gastrointestinal tract | Salmonella spp. |
Skin | Staphylococcus aureus |
Infectious Dose (ID50) vs. Lethal Dose (LD50)
These metrics quantify pathogen virulence.
ID50: Infectious dose for 50% of the population.
LD50: Lethal dose for 50% of the population.
Lower values indicate higher virulence.
Virulence Factors
Adhesins: Surface molecules that bind to host receptors, facilitating attachment.
Capsules: Polysaccharide layers that inhibit phagocytosis.
Cell Wall Components: Such as M protein, which resists phagocytosis.
Antigenic Variation: Pathogens alter surface proteins to evade immune detection.
Exoenzymes: Enzymes that degrade host tissues.
Coagulases: Clot fibrinogen, protecting bacteria from immune cells.
Kinases: Digest clots; e.g., streptokinase used to treat heart attacks.
Hyaluronidase: Breaks down connective tissue.
Collagenase: Degrades collagen in connective tissue.
Invasins & Siderophores: Facilitate invasion and iron acquisition.
Toxins: Substances that damage host cells.
Exotoxins: Secreted proteins; highly toxic and specific.
Endotoxins: Lipopolysaccharide components of Gram-negative bacteria; released upon cell death.
Table 15.2 & 15.3: (Types and effects of toxins.)
Toxin Type | Source | Effect |
|---|---|---|
Exotoxin | Gram-positive bacteria | Specific tissue damage |
Endotoxin | Gram-negative bacteria | Fever, shock |
Innate Immunity
Definitions and Overview
Innate immunity is the body's first line of defense, providing immediate, non-specific protection against pathogens.
Immunity: Ability to resist infection.
Susceptibility: Lack of resistance to disease.
Resistance: Ability to ward off disease.
Cytokines: Signaling proteins that regulate immune responses.
Features of the Immune System
Physical and chemical barriers
Recognition of pathogens
Distinguishing self from non-self
Memory (mainly adaptive immunity)
Regulation to prevent overreaction
Innate vs. Adaptive Immunity
Innate Immunity: Non-specific, immediate response.
Adaptive Immunity: Specific, slower response with memory.
Physical and Chemical Barriers
First Line Defense: Skin, tears, mucus prevent pathogen entry.
Chemical Factors: Lysozyme in tears, acidic pH of skin and stomach.
Second Line Defense
Blood Components: Plasma, cells (leukocytes).
Leukocytes:
Monocytes/Macrophages: Phagocytosis.
Dendritic Cells: Antigen presentation.
Neutrophils: Phagocytosis, first responders.
Basophils: Release histamine.
Eosinophils: Combat parasites, allergic responses.
Blood Separation: Technique to analyze blood components; white blood cell count can indicate infection or immune status.
Lymphatic System
Lymph: Fluid containing immune cells.
Lymph Vessels: Transport lymph; related to but separate from blood vessels.
Lymph Nodes: Filter lymph, house immune cells.
Phagocytosis
Phagocytosis is the process by which immune cells ingest and destroy pathogens.
Steps: Chemotaxis, adherence, ingestion, digestion, discharge of waste.
Some microbes evade phagocytosis via capsules or other mechanisms, complicating infection control.
Inflammation
Definition: Localized response to injury or infection.
Acute vs. Chronic: Acute is short-term; chronic is prolonged and damaging.
Three Stages: Vasodilation, phagocyte migration, tissue repair.
Histamine: Increases blood vessel permeability, promoting inflammation.
Fever
Increased body temperature due to infection.
Blood vessels constrict, metabolism increases, shivering generates heat.
Cytokines mediate fever; can help fight infection but may be harmful if excessive.
Interferons
Proteins produced in response to viral infection.
Induce uninfected cells to produce antiviral proteins, limiting viral spread.
Adaptive Immunity
Overview and Definitions
Adaptive immunity provides specific, long-lasting protection through the actions of lymphocytes and the production of antibodies.
Two Components: Humoral and cellular immunity.
Humoral Immunity
Antibodies: Proteins produced by B cells in response to antigens.
B Cells: Produce antibodies and memory cells for future exposures.
Antigen: Substance that elicits an immune response.
Antibody: Protein that binds specifically to an antigen.
Cellular Immunity
T Cells: Mediate cellular immunity.
T Helper (TH) Cells: Activate other immune cells.
Cytotoxic T Lymphocytes (CTLs): Kill infected or abnormal cells.
Important for pathogens hiding inside cells or for eliminating cancerous cells.
Types of Adaptive Immunity
Type | How Acquired | Example |
|---|---|---|
Naturally Acquired Active | Infection | Chickenpox recovery |
Naturally Acquired Passive | Maternal antibodies | Placental transfer |
Artificially Acquired Active | Vaccination | MMR vaccine |
Artificially Acquired Passive | Injection of antibodies | Antivenom |
Vaccines
Overview
Vaccines stimulate adaptive immunity to provide protection against specific pathogens.
Adjuvant: Substance added to enhance immune response.
Monoclonal Antibody: Laboratory-produced antibody for diagnostics or therapy.
Vaccines can target viruses, bacteria, or both.
Types of Vaccines
Live Attenuated: Weakened form of the pathogen.
Inactivated: Killed pathogen.
Subunit: Contains only parts of the pathogen.
Toxoid: Inactivated toxins.
Conjugate: Linked to a carrier protein.
Some types may pose risks if the pathogen reverts to virulence or in immunocompromised individuals.
Improving Vaccine Efficacy
Use of adjuvants
Booster doses
Recombinant technology
Immunological-Based Tests
Detect antibodies or antigens in patient samples.
Examples: ELISA, rapid strep test.
Positive result indicates presence of pathogen or immune response.
Antimicrobial Drugs
Overview and Terminology
Chemotherapy: Use of chemicals to treat disease.
Antimicrobial Drugs: Compounds that kill or inhibit microbes.
Antibiotic: Substance produced by microorganisms that inhibits others.
Selective Toxicity
Drugs should target microbes without harming human cells.
Bactericidal vs. Bacteriostatic
Bactericidal: Kills bacteria.
Bacteriostatic: Inhibits bacterial growth.
Antibiotics and Viruses
Antibiotics do not kill viruses (e.g., cold, influenza, COVID-19).
Targets of Antimicrobial Drugs
Cell Wall Synthesis: Penicillins, cephalosporins; bacteria may resist via beta-lactamase production.
Protein Synthesis: Tetracyclines, macrolides.
Plasma Membrane: Polymyxins.
Nucleic Acid Synthesis: Quinolones, rifampin.
Metabolic Pathways: Sulfonamides.
Antifungal and Antiviral Drugs
Antifungals: Target ergosterol in fungal membranes (e.g., amphotericin B).
Antivirals: Inhibit viral replication (e.g., acyclovir for herpes).
Antimicrobial Drug Synergy
Combined use of drugs for enhanced effect (e.g., trimethoprim-sulfamethoxazole).
Antibiotic Resistance
Occurs via mutation or gene transfer.
Human factors: Overuse, misuse, incomplete courses.
Mechanisms: Enzyme production (e.g., beta-lactamase), altered targets, efflux pumps.
Example: MRSA (Methicillin-resistant Staphylococcus aureus).
Figure 20.17: Disk diffusion method for testing antibiotic susceptibility.
Table 20.3: (Common antimicrobial drugs and their actions.)
Drug | Target | Example Disease |
|---|---|---|
Penicillin | Cell wall synthesis | Strep throat |
Tetracycline | Protein synthesis | Acne |
Polymyxin B | Plasma membrane | Pseudomonas infection |
Rifampin | RNA synthesis | Tuberculosis |
Additional info: For all tables, content is inferred and representative based on standard microbiology textbooks.